ganirelix acetate injection, solution
organon usa inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate 250 ug in 0.5 ml - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components including dry natural rubber/latex (see how supplied). - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).
ganirelix acetate injection, solution
ferring pharmaceuticals inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).
ganirelix acetate injection, solution
organon llc - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components including dry natural rubber/latex which may be contained in the rigid needle shield (see how supplied). - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).
ganirelix acetate injection, solution
meitheal pharmaceuticals inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components including dry natural rubber/latex (see how supplied ). - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions ).
ganirelix acetate injection
amphastar pharmaceuticals, inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).
ganirelix acetate injection, solution
gland pharma limited - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: • known hypersensitivity to ganirelix acetate or to any of its components. • known hypersensitivity to gnrh or any other gnrh analog. • known or suspected pregnancy (see precautions).
ganirelix acetate injection
fresenius kabi usa, llc - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).
ganirelix acetate injection, solution
sun pharmaceutical industries, inc. - ganirelix acetate (unii: 56u7906fqw) (ganirelix - unii:ix503l9wn0) - ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation. ganirelix acetate injection is contraindicated under the following conditions: - known hypersensitivity to ganirelix acetate or to any of its components. - known hypersensitivity to gnrh or any other gnrh analog. - known or suspected pregnancy (see precautions).
ganirelix sun ganirelix (as acetate) 250 microgram/0.5 ml solution for injection prefilled syringe
sun pharma anz pty ltd - ganirelix acetate, quantity: 0.269 mg (equivalent: ganirelix, qty 0.25 mg) - injection, solution - excipient ingredients: glacial acetic acid; sodium hydroxide; mannitol; water for injections - for the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.
ganirelix theramex ganirelix (as acetate) 250 microgram/0.5 ml solution for injection prefilled syringe
theramex australia pty ltd - ganirelix, quantity: 0.25 mg - injection, solution - excipient ingredients: glacial acetic acid; water for injections; mannitol; sodium hydroxide - for the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques